Osteosarcopenia in patients with non-dialysis dependent chronic kidney disease

被引:8
|
作者
Montenegro, Julia [1 ]
Klein, Arcia Regina Simas Torres [2 ]
Bregman, Rachel [3 ]
Prado, Carla M. [1 ]
Silva, Maria Ines Barreto [1 ,2 ,4 ]
机构
[1] Univ Alberta, Human Nutr Res Unit, Dept Agr Food & Nutr Sci, Div Human Nutr, Edmonton, AB T6G 2E1, Canada
[2] Univ Estado Rio De Janeiro, Inst Nutr, Dept Appl Nutr, BR-20550900 Rio De Janeiro, Brazil
[3] Univ Estado Rio De Janeiro, Div Nephrol, BR-20550900 Rio De Janeiro, Brazil
[4] Fed Univ State Rio de Janeiro, Sch Nutr, Dept Appl Nutr, BR-22290240 Rio De Janeiro, Brazil
关键词
Bone mineral density; Osteosarcopenia; Muscle quality index; Chronic kidney disease; BONE-MINERAL DENSITY; BODY-COMPOSITION; INSULIN-RESISTANCE; MUSCLE QUALITY; ASSOCIATION; METABOLISM; MEN; CLASSIFICATION; PREVALENCE; SARCOPENIA;
D O I
10.1016/j.clnu.2022.04.017
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Introduction: Chronic kidney disease (CKD) is associated with a reduction in bone mineral density (BMD), but less is understood regarding the relation between BMD and muscle mass, especially in non-dialysis dependent-CKD (NDD-CKD). The aim of this study was to explore the prevalence and association of low BMD (osteopenia and osteoporosis) with markers of muscle mass and function in patients with NDDCKD. Methodology: This cross-sectional observational study included patients with NDD-CKD. Routine biochemical parameters including those related to mineral and bone metabolism were evaluated. Body composition was assessed by dual energy x-ray absorptiometry (DXA) for BMD (g/cm2), total and trunk body fat (%), total lean soft tissue (LST; kg), and appendicular skeletal muscle mass (ASM; kg) as the sum of the LST from the limbs. The latter two variables were used as markers of muscle mass, together with its height indexed values: ASM/height2 as ASM index (ASMI; kg/m2), and LST/height2 as LST index (LSTI, kg/m2). Muscle quality index (MQI) was calculated as handgrip strength (HGS)/mean ASMarms (kg/kg). Osteosarcopenia was defined according to referenced cut-points for patients presenting with low ASMI, HGS and BMD. Results: Patients (n = 257, 57.6% males) had a mean age = 64.8 ?? 12.9 years, estimated glomerular filtration rate (eGFR) = 30.1 ?? 12.9 ml/min and body mass index (BMI) = 26.8 ?? 4.8 kg/m2. Patients with low BMD (39.4%) presented with lower BMI, LST, LSTI, ASM and ASMI for both sexes. BMD was positively and significantly correlated with LST, LSTI, ASM, ASMI and HGS. Low ASM was associated with low BMD (odds-ratio-OR; 95% confidence interval-CI: males OR = 4.54, 2.02-10.21; females OR = 4.45, 1.66 -11.93). Linear multiple regression analysis (adjusted for sex and eGFR) showed significant associations between T-score with HGS (R2 = 0.288, R2 adjusted = 0.272, standardized coefficient f3 = 0.536, p < 0.0001) and also with MQI (R2 = 0.095, R2 adjusted = 0.075, standardized coefficient f3 = 0.309, p = 0.024). Osteosarcopenia was present in about 7% of participants and similarly distributed between sexes. Conclusion: Low BMD was prevalent, and associated with low markers of muscle mass and quality, in NDD-CKD patients of both sexes. In view of the known significance of these conditions, targeted interventions are needed to optimize body composition and functional status of these patients. 0 2022 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:1218 / 1227
页数:10
相关论文
共 50 条
  • [21] Impact of volume status on sarcopenia in non-dialysis chronic kidney disease patients
    Seok Hui Kang
    Jun Chul Kim
    Ran-hui Cha
    Miyeun Han
    Won Suk An
    Su Hyun Kim
    Jun Young Do
    Scientific Reports, 12
  • [22] Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney disease
    Karangizi, A. H. K.
    Chanouzas, D.
    Fenton, A.
    Moss, P.
    Cockwell, P.
    Ferro, C. J.
    Harper, L.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2020, 113 (04) : 253 - 257
  • [23] Enarodustat Treatment for Renal Anemia in Patients With Non-dialysis Chronic Kidney Disease
    Mima, Akira
    IN VIVO, 2023, 37 (02): : 825 - 829
  • [24] Impact of non-dialysis chronic kidney disease on survival in patients with septic shock
    Maizel, Julien
    Deransy, Romain
    Dehedin, Benedicte
    Secq, Edouard
    Zogheib, Elie
    Lewandowski, Elisabeth
    Tribouilloy, Chritstophe
    Massy, Ziad A.
    Choukroun, Gabriel
    Slama, Michel
    BMC NEPHROLOGY, 2013, 14
  • [25] PATTERNS OF HOSPITAL ADMISSIONS AMONG NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS
    Diwan, Vishal
    Zhang, Jenny
    Wang, Zaimin
    Healy, Helen
    Hoy, Wendy
    NEPHROLOGY, 2022, 27 : 85 - 85
  • [26] EFFECTS OF ALLOCATION TO SACUBITRIL/VALSARTAN IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE
    Tong, J.
    Ren, H.
    Ma, X. Y.
    Zhang, B. Y.
    Lin, L.
    Liu, N.
    Li, X.
    Xie, J. Y.
    Chen, N.
    NEPHROLOGY, 2021, 26 : 34 - 34
  • [27] Hip fracture in patients with non-dialysis chronic kidney disease stage 5
    Chao-Hsiun Tang
    Che-Yi Chou
    Scientific Reports, 11
  • [28] Impact of non-dialysis chronic kidney disease on survival in patients with septic shock
    Julien Maizel
    Romain Deransy
    Benedicte Dehedin
    Edouard Secq
    Elie Zogheib
    Elisabeth Lewandowski
    Chritstophe Tribouilloy
    Ziad A Massy
    Gabriel Choukroun
    Michel Slama
    BMC Nephrology, 14
  • [29] Hip fracture in patients with non-dialysis chronic kidney disease stage 5
    Tang, Chao-Hsiun
    Chou, Che-Yi
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [30] Sarcopenia in Non-Dialysis Chronic Kidney Disease Patients: Prevalence and Associated Factors
    De Amorim, Geraldo Jose
    Calado, Cinthia Katiane Martins
    Souza de Oliveira, Bruno Carlos
    Araujo, Renata Patricia Oliveira
    Filgueira, Tayrine Ordonio
    De Sousa Fernandes, Matheus Santos
    Castoldi, Angela
    Vajgel, Gisele
    Valente, Lucila Maria
    De Lima-Filho, Jose Luiz
    Carvalho, Paulo Roberto Cavalcanti
    Souto, Fabricio Oliveira
    FRONTIERS IN MEDICINE, 2022, 9